Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Chi Leung Chiang"'
Autor:
Chi Leung Chiang, Tai Chung Lam, Chung Bong James Li, Wing Sum Li, Sik-Kwan Chan, Yim Ping Yolanda Lee, Ka Wai Alice Cheung, James Chung Hang Chow, Po Chung Sunny Chan, Wai Man, Sarah Lee, Wing Yu Jessica Lai, Aya El Helali, Wai-Tong Ng, Feng-Ming Spring Kong, Dora LW Kwong, Wing Mui Anne Lee
Publikováno v:
Journal of Clinical Oncology. 40:e18029-e18029
e18029 Background: Patients with recurrent or metastatic nasopharyngeal cancer (R/M NPC) who failed platinum-based chemotherapy have poor prognoses. We report the clinical activity and safety of bintrafusp alfa, a first-in-class bifunctional fusion p
Autor:
Chi Leung Chiang, Wan Hang Keith Chiu, Wing Hang Vince Lau, Sik-Kwan Chan, Ann Shing Lee, Feng-Ming Spring Kong, Albert Chan
Publikováno v:
Journal of Clinical Oncology. 40:4091-4091
4091 Background: Previous studies proposed therapeutic synergy between loco-regional therapies and checkpoint inhibitors in hepatocellular carcinoma (HCC). We aimed to study the safety and efficacy of sequential transarterial chemoembolization (TACE)
Autor:
Sik-Kwan Chan, Wan Hang Keith Chiu, Ho Fun Victor Lee, Varut Vardhanabhuti, Tan To Cheung, Albert Chan, Stephen L. Chan, Pek-Lan Khong, Kelvin Kwok Chai Ng, Wai-Kay Seto, Feng-Ming Spring Kong, Chi Leung Chiang
Publikováno v:
Journal of Clinical Oncology. 40:e16176-e16176
e16176 Background: Dual-tracer positron emission tomography/computed tomography (PET/CT) with 18F-fluorodeoxyglucose and 11C-acetate is increasingly used in the management of hepatocellular carcinoma (HCC). However, considering the high cost of dual-
Autor:
Wei Dai, Zhao-Chong Zeng, Wei Zhang, Hao Yu, Chi-Leung Chiang, Guo-Ming Shi, F.M. Kong, Shisuo Du, Albert C. Y. Chan, Chen Hu
Publikováno v:
Journal of Clinical Oncology. 38:e14057-e14057
e14057 Background: This study aimed to investigate the prognostic value of transcriptome and clinical data of Hepatocellular carcinoma (HCC) patients for overall survival (OS) by deep learning method. Methods: A total of 371 HCC patients with 20530 l
Autor:
Steven Wai Kwan Siu, Maria Lai, Chi-Leung Chiang, Philip W.K. Kwong, Stewart Y. Tung, Benny Zee, Ashley Cheng, Ann Sing Lee, Conrad Lee, Jacques Jolivet, FY Cheung, Marc K. C. Chong, Chloe Kwok, Kwok Leung
Publikováno v:
Journal of Clinical Oncology. 30:4105-4105
4105 Background: XIAP inhibits caspases which are proteases responsible for apoptotic cell death. It is highly expressed in HCC. AEG35156 is a second generation antisense oligonucleotide targeting XIAP mRNA, thus lowers the apoptotic threshold of can